“once weekly dosing with everolimus seemed to give similar efficacy with maybe lower potential side effect risk”
Main Takeaways:
- Weekly dosing of everolimus may be as effective as more frequent dosing.
- Weekly dosing could potentially have fewer side effects.
- This dosing schedule might be easier for pet owners to manage.
Notes: Discussion about dosing frequency in a veterinary context
Tone: cautious
Relevance: 4/5
“we have this one study using everus that show that gives us a hint that says hey this might actually enhance immune function in people in their mid-60s but we need the follow-up study”
Main Takeaways:
- Everus may enhance immune function in individuals in their mid-60s.
- Further studies are required to confirm these findings.
- The study hints at potential geroprotective effects of Everus.
Notes: Discussing the potential of geroprotective drugs
Tone: Cautious
Relevance: 4/5
“my conviction around mtor is far more based on the experimental data um something that is actually sorely lacking in the NAD story which we'll discuss so the experimental data are far more convincing right which is when you look at the administration of Ramy or its analoges for example ever alus um when you look at the administration of these molecules to organisms that are as close as possible to the species of interest.”
Main Takeaways:
- The speaker's belief in the effectiveness of mTOR inhibitors like rapamycin is based on experimental data.
- Highlights the lack of convincing data for NAD compared to mTOR inhibitors.
- Discusses the administration of rapamycin and its analogs to various organisms close to humans in biological terms.
Notes: Comparing experimental data of mTOR inhibitors and NAD
Tone: Confident
Relevance: 4/5
“Joan manik um and Lloyd klickstein when they published that paper in 2014 using everolimus where they took a group of 65y olds and randomize them to either a placebo or different Doses and dosing schedules of everolimus found an enhanced immunity in response to an influenza vaccine”
Main Takeaways:
- Everolimus was studied for its effects on enhancing immunity in older adults.
- The study involved randomizing participants to receive either everolimus or a placebo.
- Results showed improved immune response to influenza vaccination among those who received everolimus.
Notes: Discussion on the potential of everolimus as an immune enhancer.
Tone: Informative
Relevance: 5/5
No comments yet.